)
)
)
Sebastian BioPharma
Sebastian BioPharma is a preclinical oncology company developing tumor-targeted, multi-pathway therapeutics for colorectal cancer and other immunotherapy-resistant solid tumors. Our lead program uses a dual payload antibody–oligonucleotide conjugate approach designed to overcome tumor immune escape while reducing systemic toxicity, with expansion potential across additional solid tumors.
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
